диагностический центр онкологии
Middle age of patients has made 64 years; 84 % had positive рецепторный the status, 34 % - positive axillary лимфоузлы, 21 % of patients received адъювантную chemotherapy earlier. Reception анастрозола associated with reduction of risk рецидивирования on 17 % (1 % in absolute values) in comparison with тамоксифеном (р=0,0129); the combination анастрозола and тамоксифена did not differ on efficiency from monotherapy тамоксифеном. It is necessary to note, that reception анастрозола associated also with essential decrease{reduction} in risk of development контралатерального a cancer dairy железы (р=0,0068). Костно-muscular pains, and also crises of bones much more often were observed in group анастрозола while тромбоэмболические episodes and gynecologic complications, including a cancer эндометрия, much more often met in group тамоксифена. Thus, анастрозол it can be considered{examined} as alternative тамоксифену at patients in менопаузе with positive receptors. Reception анастрозола has considerably lowered frequency of development контралатерального a cancer, and this fact is the basis for studying group ингибиторов ароматазы as means of preventive maintenance of a cancer dairy железы in groups with the raised{increased} risk. Подробнее...
The second purpose of operative treatment of the widespread cancer яичников is removal{distance} or the maximal resection as primariest tumour, and all its{her} metastasises. Removal{distance} of a great bulk of a tumour improves the general{common} condition of patients due to reduction of an intoxication and normalization of function of intestines. Besides циторедукция raises efficiency of the subsequent chemotherapy due to reduction of number of tumoral cells{cages} including resistant to chemotherapy, transition of the most part of the staying cells{cages} from a phase of rest in a phase of division, and removal{distance} it is bad васкуляризованных sites of a tumour in which hit of antineoplastic preparations is complicated. Подробнее...
